Tenofovir Alafenamide (TAF) in Adolescents with Chronic Hepatitis B Virus Infection (GS-US-320-1092)
To find out the effects of tenofovir alafenamide (TAF) on children and adolescents with chronic hepatitis B.
To find out the effects of tenofovir alafenamide (TAF) on children and adolescents with chronic hepatitis B.
To evaluate the efficacy of tofacitinib based on remission in pediatric participants with moderately to severely active Ulcerative Colitis (UC).